§ Funding Round
Gracell Biotechnologies raised $100M Series C venture round, led by Morningside Ventures.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
King Star Med | — | — |
| Organization | — | |
Morningside VenturesLEAD | — | — |
OrbiMedLEAD | Organization | — |
Temasek Holdings | — | — |
| Organization | — | |
| Organization | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$185M
Top Valuation
-
Gracell Biotechnologies raised $100M in a Series C round.
The round was announced on 10/29/20.
The round was led by Morningside Ventures, OrbiMed, Wellington Management.
